| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $21.3M | -13.7% |
| SG&A Expense | $9.6M | -18.2% |
| Operating Income | -$41.5M | +6.9% |
| Interest Expense | $850K | +0.0% |
| Pre-tax Income | -$36.2M | -104.3% |
| Income Tax | $7K | -46.2% |
| Net Income | -$36.2M | -104.2% |
| EPS (Basic) | $22.19 | +1409.5% |
| EPS (Diluted) | $22.19 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.4M | -74.1% |
| Current Assets | $5.6M | -72.8% |
| Total Assets | $5.8M | -86.6% |
| Current Liabilities | $6.4M | -22.8% |
| Stockholders' Equity | -$1.3M | -105.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.4M | +28.6% |
| Capital Expenditures | $2K | -93.3% |
| Investing Cash Flow | $108K | -84.9% |
| Financing Cash Flow | $13.2M | -65.6% |
| Free Cash Flow | -$26.4M | +28.7% |
| +560.4% |